|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Binding of urokinase-type plasminogen activator receptor to the mannose 6-phosphat/insulin-like growth factor Ⅱ receptor:contrasting interactions of full-length and soluble form of uPAR显示文摘 | Kreiling JL Byrd JC Deisz R J | 2003 | J Biol Chem2003，278，20： | 1 |
| 2 | Repetitive cycles of high dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16:16)(p13:q22): results from CALGB 8461显示文摘 | Byrd JC Ruppert AS Mr 6 zek K | 2004 | J Clin Oncol2004，22，6： | 1 |
| 3 | Opposing role for the insulin-like growth factor(IGF)-Ⅱ and mannose 6-phosphate(Man-6-P) binding activities of the IGF-Ⅱ/Man-6-P receptor in the growth of prostate cancer cells显示文摘 | Schaffer BS Lin MF Byrd JC | 2002 | Endocrinology2002，144，3： | 1 |
| 4 | Clinical safety and activity in a phase 1 study of CAL-101,an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110,in patients with relapsed or refractory non-Hodgkin lymphoma显示文摘 | Kahl B Byrd JC Flinn IW | 2010 | Blood (ASH Annual Meeting Abstracts)2010，116，： | 1 |
| 5 | Expression of the endogenous galactose-binding protein galectin-3correlates with the malignant potential of tumors in the centralnervous system显示文摘 | Bresalier RS Yan PS Byrd JC | 2008 | Cancer2008，80，4： | 1 |
| 6 | Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia:A clinical review显示文摘 | Byrd JC Edenfield WJ Shields DJ | 1995 | J Clin Oncol1995，13，7： | 1 |
| 7 | Central photorefractive kera-tectomy for myopia;partially sighted and normally sighted eyes显示文摘 | McDonald MB Liu JC Byrd TJ | 1991 | Ophthalmology1991，98，： | 1 |
| 8 | A phase 1 and pharmacodynamic study of depsipeptide ( FK228 ) in chronic lymphocytic leukemia and acute myeloid leukemia显示文摘 | Byrd JC Marcucci G Parthun MR | 2005 | Blood2005，105，7： | 1 |
| 9 | select high - risk genetic features predict earlier pro- gression following chemoimmunotherapy with fludarabine and rituximab in chronic lympho- cytic leukemia: justification for risk -adapted therapy显示文摘 | Byrd JC Gribben JG Peterson | 2006 | J Clin Onco12006，24，3： | 1 |
| 10 | Atypical lymphocytic lobular panniculitis显示文摘 | Magro M Crowson AN Byrd JC | 2004 | J Cutan Pathol2004，31，4： | 1 |
| 11 | Rituximab: Converging mechanisms of action in non-Hodgkin' s lymphoma? 显示文摘 | Eisenbeis CF Caligiuri MA Byrd JC | 2003 | Clin Cancer Res2003，9，161： | 1 |
| 12 | Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101 显示文摘 | Lin TS Donohue KA Byrd JC | 2010 | J Clin Oncol2010，28，29： | 1 |
| 13 | Phase 1/2 study of lumiliximab combined with fludarabine,cyclophosphamide,and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia显示文摘 | Byrd JC Kipps TJ Flinn IW | 2010 | Blood2010，115，5： | 1 |
| 14 | Pretreatment cytogenetic abnormalities are predictive of induction success,cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia:results from Cancer and Leukemia Group B (CALGB 8461)显示文摘 | Byrd JC Mr6zek K Dodge RK | 2002 | {H}Blood2002，，13： | 1 |
| 15 | Phase 1/2 study of lumilix- imab combined with fludarabine, cyclophosphamide, and ritux- imab in patients with relapsed or refractory chronic lymphocyt- ic leukemia显示文摘 | Byrd JC Kipps TJ Flinn IW | 2010 | Blood2010，115，： | 1 |
| 16 | Expression of the endogenousgalactose-binding protein galectin-3 correlates with the malignantpotential of tumors in the central nervous system 显示文摘 | Bresaiier RS Yan PS Byrd JC | 1997 | Cancer1997，80，4： | 1 |
| 17 | Phase 1 and pharmacodynamic studies of G3139,a bcl-2 antisense oligonudeotide,in combination with chemotherapy in refractory or relapsed acute leukemia显示文摘 | Marcucci G Byrd JC Dai G | 2003 | Blood2003，101，2： | 1 |
| 18 | FTY720 induces apop-tosis in hepatocellular carcinoma cells through activationof protein kinase C delta signaling显示文摘 | Kulp SK Muthusamy N Byrd JC | 2007 | Cancer Res2007，68，4： | 1 |
| 19 | Pretreatment cytogenetic abnormalities are predictive of induction success,cumulative incidence of relapse,and overall survival in adult patients with de novo acute myeloid leukemia:Results from Cancer and Leukemia Group B(CALGB8461)显示文摘 | Byrd JC Mrózek K Dodge RK | 2002 | Blood2002，100，13： | 1 |
| 20 | Extramedullarymyeloid cell tumors in acute nonlymphocytic leukemia : aclinical review显示文摘 | Byrd JC Edenfield WJ Shields DJ | 1995 | J Clin Oncol1995，13，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员